Literature DB >> 19541944

CT lung cancer screening in the UK.

A J Edey1, D M Hansell.   

Abstract

Lung cancer is the most common cause of cancer-related death in the UK. Despite aggressive primary prevention measures and improved medical care, the 5-year survival rate is less than 10% for patients in the UK who present with symptoms. The possibility of CT screening for lung cancer provides some hope of reducing mortality. However, the case for screening remains unproven. This article explores the issues surrounding lung cancer screening in the context of historical studies, trials in progress and tentative plans for a UK CT lung cancer screening trial.

Entities:  

Mesh:

Year:  2009        PMID: 19541944     DOI: 10.1259/bjr/17503608

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  U.S. primary care physicians' lung cancer screening beliefs and recommendations.

Authors:  Carrie N Klabunde; Pamela M Marcus; Gerard A Silvestri; Paul K J Han; Thomas B Richards; Gigi Yuan; Stephen E Marcus; Sally W Vernon
Journal:  Am J Prev Med       Date:  2010-11       Impact factor: 5.043

2.  Lung cancer screening practices of primary care physicians: results from a national survey.

Authors:  Carrie N Klabunde; Pamela M Marcus; Paul K J Han; Thomas B Richards; Sally W Vernon; Gigi Yuan; Gerard A Silvestri
Journal:  Ann Fam Med       Date:  2012 Mar-Apr       Impact factor: 5.166

3.  Ethics and principles in medical monitoring of populations exposed to environmental hazards.

Authors:  Michael Gochfeld; John D Bogden; Donald B Louria
Journal:  J Occup Environ Med       Date:  2009-12       Impact factor: 2.162

4.  Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer.

Authors:  Michela Terlizzi; Chiara Colarusso; Ilaria De Rosa; Nicolina De Rosa; Pasquale Somma; Carlo Curcio; Alessandro Sanduzzi; Pietro Micheli; Antonio Molino; Antonello Saccomanno; Rosario Salvi; Rita P Aquino; Aldo Pinto; Rosalinda Sorrentino
Journal:  Oncotarget       Date:  2018-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.